<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Spectral Med Inc — News on 6ix</title>
<link>https://6ix.com/company/spectral-med-inc</link>
<description>Latest news and press releases for Spectral Med Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 01 Apr 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/spectral-med-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f84378dffbe2df130692.webp</url>
<title>Spectral Med Inc</title>
<link>https://6ix.com/company/spectral-med-inc</link>
</image>
<item>
<title>Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-announces-participation-in-the-2026-bloom-burton-and-co-healthcare-investor-conference</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-announces-participation-in-the-2026-bloom-burton-and-co-healthcare-investor-conference</guid>
<pubDate>Wed, 01 Apr 2026 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-s...</description>
</item>
<item>
<title>Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and&#xA0;Provides Corporate Update</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-fourth-quarter-and-fiscal-2025-results-andandxa0provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-fourth-quarter-and-fiscal-2025-results-andandxa0provides-corporate-update</guid>
<pubDate>Thu, 26 Mar 2026 11:30:00 GMT</pubDate>
<description>TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (&#x201C;Spectral&#x201D; or t...</description>
</item>
<item>
<title>Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-and-vantive-announce-publication-of-complete-results-from-spectrals-tigris-trial-in-the-lancet-respiratory-medicine</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-and-vantive-announce-publication-of-complete-results-from-spectrals-tigris-trial-in-the-lancet-respiratory-medicine</guid>
<pubDate>Tue, 24 Mar 2026 11:00:00 GMT</pubDate>
<description>Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% a...</description>
</item>
<item>
<title>Spectral Medical Provides Update on PMA Submission Timing for PMX-20R</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-provides-update-on-pma-submission-timing-for-pmx-20r</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-provides-update-on-pma-submission-timing-for-pmx-20r</guid>
<pubDate>Thu, 26 Feb 2026 12:30:00 GMT</pubDate>
<description>TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the timing of its Premarket Approval (“PMA”) submission to the U.S. Food and Drug Administration (“FDA”) for its hemoadsorption device to treat endotoxic septic shock. Following recent interaction with the FDA, the Company now expects to submit its PMA around the end of Ap</description>
</item>
<item>
<title>Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-third-quarter-2025-financial-results-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-third-quarter-2025-financial-results-and-provides-corporate-update</guid>
<pubDate>Fri, 07 Nov 2025 12:30:00 GMT</pubDate>
<description>PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interaction...</description>
</item>
<item>
<title>Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-files-base-shelf-prospectus-and-revised-aif</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-files-base-shelf-prospectus-and-revised-aif</guid>
<pubDate>Mon, 29 Sep 2025 15:22:15 GMT</pubDate>
<description>TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (&#x201C; Spectral&#x201D...</description>
</item>
<item>
<title>Spectral Medical Announces Publication of EDEN Observational Study</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-publication-of-eden-observational-study</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-publication-of-eden-observational-study</guid>
<pubDate>Tue, 16 Sep 2025 11:30:00 GMT</pubDate>
<description>TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (&#x201C;Spectral&#x201D; or ...</description>
</item>
<item>
<title>Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 - 9, 2025</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-sponsors-unite-for-sepsis-symposium-chicago-september-8-9-2025</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-sponsors-unite-for-sepsis-symposium-chicago-september-8-9-2025</guid>
<pubDate>Mon, 08 Sep 2025 12:00:00 GMT</pubDate>
<description>Company to present at session titled &#x201C;Personalizing Sepsis Treatment&#x201D; T...</description>
</item>
<item>
<title>Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-sponsors-unite-sepsis-120000606</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-sponsors-unite-sepsis-120000606</guid>
<pubDate>Mon, 08 Sep 2025 12:00:00 GMT</pubDate>
<description>Company to present at session titled “Personalizing Sepsis Treatment” TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its sponsorship of the Unite for Sepsis Symposium, taking place September 8 – 9, 2025, in Chicago, Illinois. The Company also announced that Debra Foster, Clinical Consultant at Spectral Medical, will participate i</description>
</item>
<item>
<title>Spectral Medical Receives US$3 Million From Vantive</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-receives-usdollar3-million-from-vantive</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-receives-usdollar3-million-from-vantive</guid>
<pubDate>Mon, 25 Aug 2025 11:30:00 GMT</pubDate>
<description>TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (&#x201C;Spectral&#x201D; or t...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trade Resumption - EDT</title>
<link>https://6ix.com/company/spectral-med-inc/news/canadian-investment-regulatory-organization-trade-resumption-edt</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/canadian-investment-regulatory-organization-trade-resumption-edt</guid>
<pubDate>Wed, 13 Aug 2025 12:08:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trade Resumption - EDT Canada NewsWire ...</description>
</item>
<item>
<title>Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-and-vantive-announce-topline-results-from-spectrals-tigris-trial-evaluating-pmx-hemoadsorption-therapy-for-endotoxic-septic-shock</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-and-vantive-announce-topline-results-from-spectrals-tigris-trial-evaluating-pmx-hemoadsorption-therapy-for-endotoxic-septic-shock</guid>
<pubDate>Tue, 12 Aug 2025 20:00:00 GMT</pubDate>
<description>Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 2...</description>
</item>
<item>
<title>Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-vantive-announce-topline-200000715</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-vantive-announce-topline-200000715</guid>
<pubDate>Tue, 12 Aug 2025 20:00:00 GMT</pubDate>
<description>Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% posterior probability of benefit 38.7% Mortality at 28 days with PMX confirms results of prior trial subset TORONTO, Ontario and DEERFIELD, Ill., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”) (TSX: EDT), a late-stage thera</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trading Halt - EDT</title>
<link>https://6ix.com/company/spectral-med-inc/news/canadian-investment-regulatory-organization-trading-halt-edt</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/canadian-investment-regulatory-organization-trading-halt-edt</guid>
<pubDate>Tue, 12 Aug 2025 19:59:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trading Halt - EDT Canada NewsWire ...</description>
</item>
<item>
<title>Spectral Medical Announces Second Quarter and Provides Corporate Update</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-second-quarter-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-second-quarter-and-provides-corporate-update</guid>
<pubDate>Fri, 08 Aug 2025 11:30:00 GMT</pubDate>
<description>Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08,...</description>
</item>
<item>
<title>Spectral Medical Inc. Announces Filing of Base Shelf Prospectus</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-announces-filing-of-base-shelf-prospectus</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-announces-filing-of-base-shelf-prospectus</guid>
<pubDate>Fri, 04 Jul 2025 19:10:02 GMT</pubDate>
<description>TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (&#x201C; Spectral&#x201D;...</description>
</item>
<item>
<title>Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-announces-results-of-annual-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-inc-announces-results-of-annual-meeting-of-shareholders</guid>
<pubDate>Fri, 06 Jun 2025 14:59:10 GMT</pubDate>
<description>TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Compa...</description>
</item>
<item>
<title>Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-to-present-at-the-3rd-annual-hc-wainwright-bioconnect-investor-conference</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-to-present-at-the-3rd-annual-hc-wainwright-bioconnect-investor-conference</guid>
<pubDate>Fri, 16 May 2025 12:00:00 GMT</pubDate>
<description>TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (&#x201C;Spectral&#x201D; or th...</description>
</item>
<item>
<title>Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-present-3rd-annual-120000444</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-present-3rd-annual-120000444</guid>
<pubDate>Fri, 16 May 2025 12:00:00 GMT</pubDate>
<description>TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a fireside chat at the 3rd Annual H.C. Wainwright BioConnect Investor Conference, on Tuesday, May 20, 2025 at 11:30 a.m. ET at the Nasdaq headquarters in New York City, New York. Investors interested in scheduling a meeting with the Company's managem</description>
</item>
<item>
<title>Spectral Medical Announces First Quarter and Provides Corporate Update</title>
<link>https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-first-quarter-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-med-inc/news/spectral-medical-announces-first-quarter-and-provides-corporate-update</guid>
<pubDate>Fri, 09 May 2025 11:30:00 GMT</pubDate>
<description>Tigris Trial Enrollment completed Topline results expected to be released in August 2025 ...</description>
</item>
</channel>
</rss>